New medicines or medicinal products with a new active substance which still need to undergo additional monitoring will in future be identified by a black symbol with the statement “This medicinal product is subject to additional monitoring”, together with an explanatory sentence.
Valsts mēroga portāli būs saistīti ar Eiropas kopējo portālu un līdzās citai informācijai tajos būs katra produkta vērtējums.